Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2003
10/01/2003CN1446082A ÔÇ£Slow releaseÔÇØ pharmaceutical compositions comprising lithium carbonate
10/01/2003CN1446080A Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
10/01/2003CN1446079A Liposomal antineoplastic drugs and uses thereof
10/01/2003CN1446053A Food supplement
10/01/2003CN1445242A Human resourced monoclone antibody of anti-blood-vessel endothelium growth factor as well as its preparing method and medicine composition
10/01/2003CN1445237A Anagonism peptide of tumor necrosis factor and its application
10/01/2003CN1445226A New cornpound derivated from quinazoline, itd preparation method and medicinal composite containig them
10/01/2003CN1445217A Substitutional ramification of tetrahydro-isoquinoline, as well as its preparing method and its medication compound containing them
10/01/2003CN1444990A Strengthened ganoderma lucidum for possible immunoprophylaxis and immunotherapy of cancers and related diseases as well as its preparing method
10/01/2003CN1444983A Ankangxin capsule
10/01/2003CN1444975A Injection of Chinese herbal medicine for eliminating myoma in human body
10/01/2003CN1444941A Usage of substituted tetrahydroisoquinoline derviation
10/01/2003CN1444935A Application of Epigallocatechin gallate (EGCG) in anti-tumor medicine
10/01/2003CN1122669C Novel 8H thiophene [2,3-b] pyrrolinezine-8-on compound, its preparing method and their medicinal compounds containing them
10/01/2003CN1122668C Epothilone derivatives and their preparation method and their use as antitumor agents
10/01/2003CN1122662C Arylsulfonylamino hydroxamic acid derivatives
10/01/2003CN1122657C Colchicine skeleton compounds, their use as medicaments and compounds containing them
10/01/2003CN1122523C Medicine for curing malignant tumor and its preparation method
10/01/2003CN1122513C Use of compound in medicine for preparation of inhibiting pathological conditions
09/2003
09/30/2003US6627774 N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
09/30/2003US6627769 Antiproliferative agents
09/30/2003US6627754 Pyrrolo[2,3-d]pyrimidine compounds
09/30/2003US6627664 Administering perylenequinone derivative, and activating the derivative by exposing the perylenequinone to sound of a pre-determined frequency for therapy
09/30/2003US6627658 Administration of an effective amount of 15-epi-16-(para-fluoro)-phenoxy-lipoxin A4, Lipoxin-A4, 15-epi-lipoxin4 or 15-R/S-methyl-lipoxin4 or salts, esters, amides, carboxylic acids or prodrugs to treat angiogenesis
09/30/2003US6627656 Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
09/30/2003US6627655 Vanadium (IV) metallocene complexes having spermicidal activity
09/30/2003US6627650 An isomer thereof, or an addition salt thereof with a pharmaceutically acceptable acid or base. Medicinal products containing the same which are useful as anti- cancer agents.
09/30/2003US6627640 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
09/30/2003US6627638 Viricides, anticarcinogneic agents
09/30/2003US6627637 I kappa B kinase inhibitors for treating various disorders including arthritis
09/30/2003US6627634 Antitumor agents, treatment of the lungs and respiratory tract
09/30/2003US6627633 The compounds also are potent inhibitors of human cellular proliferation. As such, the compounds constitute pharmaceutical compositions with a pharmaceutically acceptable carrier. Such compounds are useful in inhibiting cellular
09/30/2003US6627629 Useful for the treatment or prevention of asthma and other allergic diseases.
09/30/2003US6627626 Antiinflammation agents and antiarthritic agents colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock animals.
09/30/2003US6627623 Induction apoptosis
09/30/2003US6627615 Methods and compositions for in vivo gene therapy
09/30/2003US6627609 Peptides which contain N-methylated amino acid units and have improved water solubility. Medicaments in which the peptides according to the invention are contained can be used for the treatment of hormone- dependent tumours and
09/30/2003US6627605 Polynucleotides which encode them, and methods for their use. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention further provides methods for diagnosing or treating disorders with
09/30/2003US6627439 Cancer diagnosis, therapy; Dna vaccine
09/30/2003US6627415 Isolated nucleic acid comprising a nucleotide sequence encoding fibrinogen-like domain; use in diagnosis and treatment of tumor angiogenesis, wound healing, thromboembolic diseases, atherosclerosis and inflammationinflammation
09/30/2003US6627405 53BP2 complexes
09/30/2003US6627231 Protecting cell from damage caused by free radicals by administering lipophilic antioxidant comprising vitamin E, beta carotene, extract of Lycopersicum esculentum, hydrophilic antioxidant comprising vitamin c, extract of vitis vinifera
09/30/2003US6627201 Comprises mixtures of agaricus blazei murrill fruiting body, mycelium extract, and chlorella growth factor; antitumor agents
09/30/2003US6627200 Utilization of CD 137 in order to promote the proliferation of peripheral monocytes
09/30/2003US6627196 Dosages for treatment with anti-ErbB2 antibodies
09/30/2003US6627176 Therapy; diagnosis
09/30/2003CA2254750C Inhibition of matrix metalloproteases by 2-(.omega.-aroylalkyl)-4-biaryl-oxobutyric acids
09/30/2003CA2133759C Evaluation and treatment of patients with progressive immunosuppression
09/30/2003CA2123321C Combination chemotherapy
09/30/2003CA2114630C Steroid sulphatase inhibitors
09/30/2003CA2102697C Pyrrolidine derivatives, preparation thereof and drugs containing same
09/29/2003CA2423915A1 Process for producing nanoparticles of paclitaxel and albumin
09/29/2003CA2423884A1 Improved paclitaxel-based antitumor formulation
09/25/2003WO2003079020A2 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
09/25/2003WO2003078646A2 Aza-thioxanthenones with antitumor activity
09/25/2003WO2003078632A1 Novel receptor polypeptides and polynucleotides encoding the same
09/25/2003WO2003078624A1 Llpl gene and novel use of its gene product
09/25/2003WO2003078623A1 Functional molecule and process for producing the same
09/25/2003WO2003078614A2 Gntiii (udp-n-acethylglucosamine:beta-d mannoside beta (1,4)-n-acethylglucosaminy ltransferase iii) expression in plants
09/25/2003WO2003078469A1 Anti-human hepatoma monoclonal antibody hab18 light/heavy chain variable region gene, and use thereof
09/25/2003WO2003078465A1 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
09/25/2003WO2003078458A2 Tap-70, a novel marker for epithelial tumors
09/25/2003WO2003078455A2 Virus like particle from papillomavirus and their use in vaccine
09/25/2003WO2003078436A1 Porphyrin derivatives, method for the production thereof, pharmaceutical compositions and use thereof
09/25/2003WO2003078435A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
09/25/2003WO2003078427A1 Azolylaminoazines as inhibitors of protein kinases
09/25/2003WO2003078426A1 Azolylaminoazine as inhibitors of protein kinases
09/25/2003WO2003078423A1 Compositions useful as inhibitors of protein kinases
09/25/2003WO2003078419A1 N-substituted benzothiophenesulfonamide derivative
09/25/2003WO2003078413A1 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
09/25/2003WO2003078410A1 Cyclic etheramine derivatives and their use for the treatment of tumors
09/25/2003WO2003078404A1 Pyrimidine derivatives
09/25/2003WO2003078403A2 Derives d’aminoindazoles comme inhibiteurs de proteine-kinase
09/25/2003WO2003078402A1 Indazoles substituted with an anti-cancerous activity
09/25/2003WO2003078398A1 NON-PEPTIDE GnRH ANTAGONISTS
09/25/2003WO2003078395A1 Piperidine derivatives useful as modulators of chemokine receptor activity
09/25/2003WO2003078386A1 Naphthylsemicarbazone, naphthylhydrazone, naphthylthiosemicarbazone, and naphthylthiohydrazone compounds and therapeutic use thereof
09/25/2003WO2003077999A1 Combination ofa cdk inhibitor and 5-fu for the treatment of cancer
09/25/2003WO2003077949A2 Methods of treating diabetes using pde 11a inhibitors
09/25/2003WO2003077948A1 Preventives/remedies for myeloma tumor and method of diagnosing the same
09/25/2003WO2003077947A1 Methods of modulating cd200 receptors
09/25/2003WO2003077945A1 Intracellular antibodies
09/25/2003WO2003077944A1 Improvements in vaccination
09/25/2003WO2003077942A2 Virus-like particles of human papillomavirus
09/25/2003WO2003077935A1 Use of enzyme inhibitors with aminopeptidase n and/or dipeptidylpeptidase iv activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states
09/25/2003WO2003077932A1 Remedies for lung cancer
09/25/2003WO2003077921A1 Azinylaminoazoles as inhibitors of protein kinases
09/25/2003WO2003077919A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
09/25/2003WO2003077915A1 Use of rapamycin for inhibiting of cell death
09/25/2003WO2003077914A1 N3 alkylated benzimidazole derivatives as mek inhibitors
09/25/2003WO2003077911A1 Photodynamic therapy for pre-melanomas
09/25/2003WO2003077909A1 Medical use of captopril for the treatment and prophylaxis of cancer
09/25/2003WO2003077906A1 Cyclic etheramine derivatives as medicaments for malignant tumors
09/25/2003WO2003077904A1 Biological activity-promoting compositions containing soybean germ-origin isoflavone aglycon
09/25/2003WO2003077897A1 Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
09/25/2003WO2003077882A2 Preparation of sterile stabilized nanodispersions
09/25/2003WO2003077874A2 Substituted tetrahydroisoquinoline compounds, methods of making, and their use
09/25/2003WO2003077865A2 Methods and compositions for directing cells to target organs
09/25/2003WO2003077864A2 Methods and compositions for directing cells to target organs
09/25/2003WO2003077862A2 Potent, simplified derivatives of immunosuppressive agents
1 ... 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 ... 2211